According to CNBC, OpenAI must not use the term “cameo” in the Sora app after a temporary restraining order was issued by Judge Eumi K. Lee of the Northern District of California. Last month, OpenAI ...

Earlier this month, we checked the specifications and did an unboxing of the Sermoon S1 high-end 3D scanner with support for blue laser and infrared scanning. I had some concerns about my host ...

A California federal judge issued a temporary restraining order Friday blocking OpenAI from using the word “Cameo” in connection with its Sora AI-generated video products. Chicago-based Cameo, the ...

This is read by an automated voice. Please report any issues or inconsistencies here. A federal judge has temporarily blocked OpenAI’s use of several monikers, including “Cameos” and “CameoVideo,” for ...

Cameo, the Chicago-based celebrity video messaging website, has become the latest company to sue OpenAI, alleging trademark infringement for the technology giant’s new service that makes AI-generated ...

The company behind the Cameo app-- which lets you pay to have celebrities create a personalized video message for you -- is suing OpenAI, alleging that a video generation feature it rolled out in late ...

Cameo has had plenty of challenges since its breakout moment as a "unicorn" startup four years ago: a slump that followed the end of pandemic, a dramatic shift in the venture capital landscape and ...

Sydney Sweeney is back on our televisions for our viewing pleasure, but this time, she showed up in a place no one expected her to. On Tuesday night, the “Euphoria” star intrigued viewers when she ...

Oct 28 (Reuters) - The maker of celebrity video platform Cameo sued OpenAI in a California federal court on Tuesday, arguing that the new "Cameo" feature of OpenAI's Sora video generation app violates ...

The logo for OpenAI, the maker of ChatGPT, appears on a mobile phone, in New York, Tuesday, Jan. 31, 2023. (AP Photo/Richard Drew) SAN FRANCISCO (CN) — Cameo, a platform that lets users pay for ...

This new clearance builds on version 3 of LungQ®, cleared by the FDA last year, which introduced advanced lung segmentation capabilities - a critical foundation for accurate analysis on a regional ...